← Agomab Therapeutics NV
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||||||
| Net Income | — | — | — | — | — | — | ($8.1m) |
($11.4m)
-39.89%
|
($46.3m)
-306.21%
|
($62.5m)
-35.19%
|
($66.7m)
-6.56%
|
|
| Net loss for the year | ($12.2m) | ($10.7m) | ($6.0m) | ($10.3m) | ($12.5m) | ($8.4m) | ($25.0m) | ($11.4m) | ($46.3m) | ($62.5m) | — | |
| Net loss on disposal of non-current assets | $2k | $16k | $137k | $1k | — | — | — | — | — | — | — | |
| Fair value loss on financial assets at fair value through profit or loss | — | — | $1.1m | — | — | — | — | — | — | — | — | |
| Depreciation & amortization | $643k | $1.4m | $1.5m | $1.1m | $1.1m | $1.3m | $1.9m | $99k | $311k | $219k | $197k | |
| Depreciation expense | — | — | — | — | — | $34k | $58k | $67k | $53k | $70k | $197k | |
| Amortization Cash Flow | — | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| Amortization Of Intangibles | — | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $23k | $99k | $311k | $219k | $197k | |
| Deferred income tax expense (income) | — | — | — | — | — | — | — | ($622k) | — | — | $0 | |
| Deferred tax liability | — | ($198k) | ($305k) | ($298k) | ($298k) | ($484k) | ($368k) | ($271k) | ($271k) | ($1.7m) | — | |
| Deferred Income Tax | — | — | — | — | — | — | ($2.7m) | ($619k) | $4k | $0 | $0 | |
| Deferred Tax | — | — | — | — | — | — | ($2.7m) | ($619k) | $4k | $0 | $0 | |
| Share-based payment expenses | $372k | $517k | $165k | $246k | $262k | $637k | $1.7m | $2.2m | $1.1m | $5.4m | — | |
| Share-based compensation | — | — | — | — | — | $2.0m | $3.2m | $1.5m | $617k | $623k | $5.2m | |
| Impairment of intangible assets | — | — | — | — | — | — | — | $0 | $0 | $13.4m | — | |
| Impairment of property, plant and equipment | ($522k) | ($12k) | $143k | $1k | — | — | — | $0 | $0 | — | — | |
| Impairment of financial assets | — | — | $2.8m | — | — | — | — | — | — | — | — | |
| Cash flows from used in operations before changes in working capital | ($11.3m) | ($7.5m) | ($10.2m) | ($7.1m) | ($10.5m) | ($3.5m) | ($23.6m) | ($19.5m) | ($19.6m) | ($10.3m) | — | |
| Change In Working Capital | — | — | — | — | — | — | $1.4m | $4.1m | ($1.3m) | $406k | $2.0m | |
| Trade and other receivables | $15k | ($4.0m) | $1.7m | $825k | $358k | ($5.0m) | ($7k) | $3.5m | $5k | $3.8m | — | |
| Change in other receivables and prepaid expenses | — | — | — | — | — | ($2.1m) | ($64k) | $903k | ($487k) | ($1.1m) | — | |
| Receivables on account of shares issued, net | — | — | — | — | — | — | — | $0 | $0 | $44k | — | |
| Increase / (decrease) in trade and other payables. | ($328k) | $573k | $88k | ($409k) | $1.7m | $1.0m | ($528k) | $3.7m | ($230k) | $2.4m | — | |
| Change in Accounts Payable | — | — | — | — | — | $1.2m | $352k | ($1.2m) | $117k | ($177k) | — | |
| Increase/(decrease) in accrued revenue | — | $41k | $97k | ($138k) | $0 | — | — | — | — | — | — | |
| Interest income accrued | ($1k) | — | — | — | — | — | — | — | — | — | — | |
| Change in accrued expenses | — | — | — | — | — | ($1.3m) | $2.8m | $45k | ($1.9m) | ($1.2m) | — | |
| Decrease/(increase) in other current assets | — | — | — | — | — | — | — | $1.3m | ($315k) | ($2.3m) | — | |
| Other assets | — | — | — | — | — | — | ($277k) | $365k | $1.0m | $100k | — | |
| Change In Other Current Assets | — | — | — | — | — | — | ($3.0m) | $1.0m | ($657k) | ($2.7m) | ($2.5m) | |
| Cash flows from investing activities | ||||||||||||
| Purchases of property, plant and equipment | — | — | — | — | — | ($239k) | ($68k) | ($3k) | $675k | $4k | — | |
| Purchase of financial investments | — | — | — | — | — | — | — | $40.0m | — | ($30.0m) | — | |
| Net cash flow from /(used in) investing activities | ($522k) | ($7.1m) | $150k | $2.4m | — | — | ($2.4m) | $40.0m | ($675k) | ($33.0m) | — | |
| Cash flows from financing activities | ||||||||||||
| Borrowings | — | — | — | — | — | — | $1.8m | ($45k) | ($1.2m) | ($238k) | — | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | ($717k) | ($100k) | ($163k) | ($338k) | ($339k) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | ($717k) | ($100k) | ($163k) | ($338k) | ($339k) | |
| Long Term Debt Payments | — | — | — | — | — | — | ($717k) | ($100k) | ($163k) | ($338k) | ($339k) | |
| Repayment Of Debt | — | — | — | — | — | — | ($717k) | ($100k) | ($163k) | ($338k) | ($339k) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $38.4m | $79.9m | $97.1m | $0 | $163.9m | |
| Common Stock Issuance | — | — | — | — | — | — | $38.4m | $79.9m | $97.1m | $0 | $163.9m | |
| Net Other Financing Charges | — | — | — | — | — | — | ($36k) | ($447k) | ($130k) | — | — | |
| Net cash flow from /(used in) financing activities | $782k |
($18k)
-102.30%
|
— | $3.8m |
$12.1m
+218.11%
|
$28.1m
+131.56%
|
$3.7m
-86.74%
|
$79.3m
+2028.93%
|
$96.8m
+21.98%
|
($338k)
-100.35%
|
— | |
| Net increase/(decrease) in cash and cash equivalents | ($11.7m) | ($18.6m) | ($8.5m) | ($539k) | $3.3m | $19.0m | ($21.4m) | $94.7m | $49.3m | ($85.1m) | — | |
| Beginning Cash Position | — | — | — | — | — | — | $53.6m | $27.7m | $122.4m | $171.5m | $143.4m | |
| Cash and cash equivalents at beginning of year | $44.4m | $14.5m | $14.5m | $6.0m | $5.4m | $27.6m | $27.6m | $122.4m | $171.5m | $86.4m | $143.4m | |
| Cash, cash equivalents and restricted cash at beginning of the year | — | — | — | — | — | $11.7m | $15.2m | $13.6m | $9.4m | $6.1m | — | |
| Change in cash, cash equivalents and restricted cash | — | — | — | — | — | $3.5m | ($1.6m) | ($4.2m) | ($3.2m) | $1.4m | — | |
| Effect of foreign exchange rate changes | $802k | ($428k) | $12k | $17k | — | ($175k) | $1.2m | $64k | ($204k) | $45k | — | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | $0 | $0 | ($204k) | $45k | $45k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Current income tax expense (income) | — | — | — | — | — | — | — | $3k | $4k | — | — | |
| Interest expense | — | — | — | — | — | — | — | $86k | $77k | $69k | — | |
| Change in operating leases | — | — | — | — | — | ($2k) | ($11k) | $13k | $35k | ($35k) | — | |
| Fair value (gain) loss on financial assets | — | — | $3.9m | $1.8m | $168k | — | — | — | — | ($96k) | — | |
| Fair value (gain) loss on financial liabilities | — | — | — | — | — | — | — | ($19.0m) | ($848k) | $4.9m | — | |
| Net foreign exchange losses (gains) | ($796k) | $454k | ($251k) | — | — | $428k | ($2.2m) | $46k | $231k | $57k | — | |
| Interest income | — | — | — | — | — | — | — | ($303k) | ($1.2m) | ($1.6m) | — | |
| Decrease/(increase) in other non-current assets | — | — | — | — | — | — | — | ($331k) | ($342k) | ($363k) | — | |
| Increase/(decrease) in deferred income | — | — | — | — | — | — | — | ($580k) | ($395k) | $747k | — | |
| Interest received | — | — | — | — | — | $74k | $972k | $245k | $1.1m | $1.6m | $1.9m | |
| Payment of contingent consideration from previous acquisition | — | — | — | — | — | — | — | — | — | ($3.0m) | — | |
| Repayment of lease liabilities | — | — | — | — | — | — | — | ($100k) | ($163k) | ($338k) | — | |
| Proceeds from capital increase | — | — | — | — | — | — | — | $79.9m | $97.1m | — | — | |
| Share issue costs | $71k | ($18k) | — | — | — | — | — | ($453k) | ($129k) | — | — | |
| Other financial expense, net | — | — | — | — | — | — | — | $6k | — | — | — | |
| Amortisation | — | — | — | — | — | — | $1.9m | $1.9m | $1.9m | $934k | — | |
| Issuance of liability classified warrants for services | — | — | — | — | — | — | $0 | $0 | $6.0m | $1.5m | — | |
| Loss/(gain) on remeasurement of contingent consideration | — | $764k | ($1.5m) | $63k | $474k | $2.6m | $0 | ($2.1m) | $134k | ($7.6m) | — | |
| Interest on unwinding of contingent consideration | — | — | — | — | — | — | — | $0 | $0 | $232k | — | |
| Gain on remeasurement of promissory note | — | — | — | — | — | — | $0 | $0 | ($25k) | $0 | — | |
| Loss / (gain) on remeasurement of financial liabilities | — | — | — | — | — | — | — | $0 | ($1.3m) | $982k | — | |
| Other provisions | ($29k) | $23k | ($58k) | ($25k) | $55k | $92k | $201k | $264k | ($349k) | $27k | — | |
| Proceeds from issuance of shares, net of transaction costs | $853k | — | — | $3.8m | $12.1m | $28.1m | $3.7m | $13.0m | $2.9m | $11.8m | — | |
| Proceeds from issuance of equity and pre-funded warrants | — | — | — | — | — | — | $0 | $0 | $2.7m | $3.0m | — | |
| Proceeds from exercise of ordinary warrants | — | — | — | — | — | — | — | $0 | $0 | $1.2m | — | |
| Proceeds from promissory note | — | — | — | — | — | — | $0 | $0 | $776k | $0 | — | |
| Repayment of promissory note | — | — | — | — | — | — | $0 | $0 | ($371k) | $0 | — | |
| Conversion of convertible promissory note | — | — | — | — | — | — | $0 | $0 | $380k | $0 | — | |
| Unissued equity | — | — | — | — | — | — | — | $0 | $0 | $380k | — | |
| Exercise of pre-funded warrants | — | — | — | — | — | — | $0 | $0 | $864k | $8.8m | — | |
| Gain on remeasurement of financial assets | — | — | — | — | — | — | $0 | $0 | ($1.3m) | — | — | |
| Payment of milestone related to contingent consideration | — | — | — | — | — | — | ($2.4m) | $0 | $0 | — | — | |
| Increase/(decrease) in prepayments | ($307k) | ($325k) | ($10k) | $398k | ($168k) | ($1.2m) | ($277k) | $365k | — | — | — | |
| Proceeds from disposal of shares | — | — | — | $2.4m | — | — | — | — | — | — | — | |
| Shares issued for no consideration | — | — | $30k | — | — | — | — | — | — | — | — | |
| Gain on legal settlement | — | — | ($8.4m) | — | — | — | — | — | — | — | — | |
| Proceeds from legal settlement | — | — | $150k | — | — | — | — | — | — | — | — | |
| Make good credit and rental adjustment | $101k | $15k | — | — | — | — | — | — | — | — | — | |
| Decrease/(increase) in income tax refund due | ($4k) | ($1k) | — | — | — | — | — | — | — | — | — | |
| (Decrease) in deposit paid | ($62k) | ($96k) | — | — | — | — | — | — | — | — | — | |
| Payments for intangibles | ($3k) | ($8k) | — | — | — | — | — | — | — | — | — | |
| Net gain on disposal of CanTx, Inc. | $569k | — | — | — | — | — | — | — | — | — | — | |
| Capital Loss | — | — | — | — | — | — | — | $0 | $0 | $7k | — | |
| Change in employees and related expenses | — | — | — | — | — | $215k | $907k | ($737k) | $111k | ($278k) | — | |
| Decrease in short-term deposits | — | — | — | — | — | — | — | $15.9m | $2.3m | $5.4m | — | |
| Proceeds from Stock Issuance | — | — | — | — | — | $10k | $143k | $0 | $0 | $12k | — | |
| Purchase of treasury share | — | — | — | — | — | $0 | ($1.2m) | $0 | $0 | — | — | |
| Sale of treasury share | — | — | — | — | — | $0 | $0 | $580k | $0 | $0 | — | |
| Issuance of shares net of issuance costs | — | — | — | — | — | $58.6m | $267k | $2.9m | $9.9m | $7.1m | — | |
| Income taxes received | — | — | — | — | — | $0 | $351k | $187k | $0 | $0 | — | |
| Right-of-use asset recognized with corresponding lease liability | — | — | — | — | — | $345k | $17k | $392k | $0 | $0 | — | |
| Issuance costs not paid in cash | — | — | — | — | — | — | — | $0 | $0 | $32k | — | |
| Investment in deposits | — | — | — | — | — | ($46.0m) | $19.6m | $15.9m | $2.3m | — | — | |
| Liabilities assumed, net of non-cash assets received in Merger | — | — | — | — | — | $49k | $0 | $0 | — | — | — | |
| Long-term lease deposit | — | — | — | — | — | $4k | $0 | $0 | — | — | — | |
| Sale of asset held for sale | — | — | — | — | — | $1.0m | $0 | $0 | — | — | — | |
| Cash acquired in Merger | — | — | — | — | — | $2.4m | $0 | $0 | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $37.6m | $79.3m | $96.8m | ($338k) | $164.9m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($44.6m) | $40.0m | ($675k) | ($33.0m) | ($30.0m) | |
| Change In Other Working Capital | — | — | — | — | — | — | $1.4m | ($580k) | ($395k) | $747k | $434k | |
| Change In Payable | — | — | — | — | — | — | $3.0m | $3.7m | ($230k) | $2.4m | $4.0m | |
| Change In Prepaid Assets | — | — | — | — | — | — | $1.4m | ($580k) | ($395k) | — | $765k | |
| Changes In Cash | — | — | — | — | — | — | ($25.9m) | $94.7m | $49.3m | ($85.1m) | $78.2m | |
| End Cash Position | — | — | — | — | — | — | $27.7m | $122.4m | $171.5m | $86.4m | $221.5m | |
| Financing Cash Flow | — | — | — | — | — | — | $37.6m |
$79.3m
+110.79%
|
$96.8m
+21.98%
|
($338k)
-100.35%
|
$164.9m
+48886.09%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($19.0m) | ($24.6m) | ($47.5m) | ($51.7m) | ($56.7m) | |
| Investing Cash Flow | — | — | — | — | — | — | ($44.6m) | $40.0m | ($675k) | ($33.0m) | ($30.0m) | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($4.6m) | $0 | $0 | ($3.0m) | $0 | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | — | $0 | $231k | $57k | ($2.1m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | — | $0 | ($675k) | ($4k) | ($4k) | |
| Operating Gains Losses | — | — | — | — | — | — | — | — | $231k | $57k | ($2.1m) | |
| Other Non Cash Items | — | — | — | — | — | — | $61k | ($217k) | ($1.1m) | ($1.5m) | — | |
| Purchase Of Business | — | — | — | — | — | — | ($4.6m) | $0 | $0 | ($3.0m) | $0 | |
| Purchase Of PPE | — | — | — | — | — | — | — | $0 | ($675k) | ($4k) | ($4k) | |
| Stock Based Compensation | — | — | — | — | — | — | $2.2m | $2.2m | $1.1m | $5.4m | $5.2m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | — | — | ($11.9m) | ($19.0m) | ($848k) | $4.8m | $4.7m | |
| Payment for purchase of business, net of cash acquired | — | ($7.1m) | — | — | — | — | — | — | — | — | — | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($40.0m) | $40.0m | $0 | ($30.0m) | ($30.0m) | |
| Sale Of Investment | — | — | — | — | — | — | — | $40.0m | $0 | — | — | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($25.9m) | $94.7m | $49.3m | ($85.1m) | — | |
| Interest paid | — | — | — | — | — | — | ($44k) | ($20k) | ($10k) | ($69k) | ($96k) | |
| Income taxes paid | — | — | — | — | — | — | ($2k) | ($3k) | ($4k) | $0 | — |